McAdams Wright Ragen’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

McAdams Wright Ragen’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-10,000	Closed	-$63K	–	378
2013 Q2	$63K	Buy	+10,000	New	+$59.9K	0.01%	337

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

McAdams Wright Ragen's PBTH Position: Q3 2013 in Review

McAdams Wright Ragen sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 10,000 shares — an estimated $63K sold.

McAdams Wright Ragen first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $63K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

McAdams Wright Ragen reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
McAdams Wright Ragen sold 10,000 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $63K.
McAdams Wright Ragen first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
McAdams Wright Ragen's PROLOR Biotech, Inc. Common Stock position peaked at $63K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on McAdams Wright Ragen's 13F filing for Q3 2013, filed 12 Nov 2013.